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A B S T R A C T
Ethylene oxide (EtO) has been categorized as “carcinogenic to humans (Group 1)” by the IARC. While
several epidemiological studies have reported carcinogenicity and EtO-Hb formation; information from
cytogenetic endpoints are rather inconclusive. In the present review, we focus on the results of eleven
studies which have reported the results of micronucleus assay in EtO exposed workers. We have critically
reviewed these studies based on the exposure assessment, concentration and duration, and compared
the sensitivity of micronucleus assay to other reported endpoints like EtO-Hb, CA, SCE. The levels of EtO
and EtO-Hb adducts in all the studies were strongly correlated to the results of SCE, but not to MN. MN
were only observed in a limited number of studies with high EtO exposure (2–28 ppm 8 h-TWA) and not
below the recommended concentration of <1 ppm. To further understand the effect of exposure of EtO on
MN assay outcome, we propose studies with more harmonized protocol for exposure assessment and MN
analysis, determination of suitable sample size and use of multiple target tissues to understand the effect
of metabolite.
ã 2016 Elsevier B.V. All rights reserved.
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Ethylene oxide (EtO) is a frequently produced organic chemical,
used as an intermediate for production of several chemicals
including ethylene glycol, ethoxylates among others. It is alsoAbbreviations: EtO, ethylene oxide; EtO-Hb adduct, ethylene oxide-haemoglo-
bin adduct; CA, chromosomal aberrations; MN, micronuclei; SCE, sister chromatid
exchanges; 8-h TWA, 8 h time weighted average.
* Corresponding author.
** Corresponding author at: KULeuven, Department of Public Health and Primary
Care, Centre Environment & Health, B-3000 Leuven, Belgium.
E-mail addresses: gmanosij@gmail.com (M. Ghosh),
lode.godderis@med.kuleuven.be (L. Godderis).
http://dx.doi.org/10.1016/j.mrrev.2016.05.002
1383-5742/ã 2016 Elsevier B.V. All rights reserved.commonly used in sterilization of medical instruments and
devices. With an estimated global production of 20 million
tonnes, it is one of the most produced organic chemicals.
The high global production of EtO increases the risks of
environmental and occupational exposure. The CAREX EU report
published in 1999 estimated the number of workers exposed to EtO
at 46900 [1]. According to the report, approximately 22300
workers were involved in medical, dental, other health services,
while 1000 workers were involved in production of EtO. Reports
from US National Occupational Exposure Survey between 1981 and
1983, estimated that approximately 270000 workers were exposed
to varying concentrations of EtO [2], of which 98997 workers
were associated with health services. More recent estimates of
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exposed to EtO at workplace, of which more than 2100 were
involved in the health care and sterilization services.
Comparison of historical data from various sources including
CAREX EU [1], IARC [4–6], US National Occupational Exposure
Survey [2], CAREX-Canada [3] clearly indicates that exposure to
workers involved in sterilization process has been much higher (1–
30 ppm), compared to exposure levels during EtO synthesis
(<1 ppm). Accidental exposure to EtO is common during and
after the sterilizing cycles as well. These exposures are usually
above the odour threshold of 500 ppm and are extremely
hazardous. Several other accounts of accidental exposure to EtO
have been reported [7–10] and is usually between 300 and
700 ppm.
While, acute exposures are known to cause nausea, bronchitis,
pulmonary oedema; workers with chronic exposure are at risk of
developing neurological disorders and cancer [11,12]. EtO is also a
known alkylating (hydroxyethylating) agent, which can lead to the
formation of adducts with DNA [13,14] and proteins like
haemoglobin [15,16]. Several cytogenetic studies, in vitro and in
vivo, have conﬁrmed the genotoxicity and mutagenicity of EtO.
Studies have also provided substantial evidence of carcinogenicity
in rodents. Over the years, several epidemiological studies have
associated EtO exposure with cancers in human [17,18] including
gastro-intestinal and breast cancers [19,20].
Based on limited evidences of toxicity, EtO was ﬁrst listed in the
Fourth Annual Report on Carcinogens in 1985 “as possible human
carcinogen”. Considering the DNA-damaging activity of EtO and
increased risk of cancer, demonstrated by epidemiological studies,
the listing was revised to “known to be a human carcinogen” in the
Ninth Report on Carcinogens in 2000 [21]. Similarly, EtO was
considered by the IARC Working Groups from 1976 to 2012, and
based on several evidences EtO has been categorized as
“carcinogenic to humans (Group 1)”.
Consequently, from an occupational perspective it is important
to adequately follow-up workers exposed to EtO at regular
intervals. Traditionally, the most common method for bio-
monitoring is the measurement of EtO metabolites (in urine) or
EtO adducts (haemoglobin and DNA). Nevertheless, cytogenetic
studies provide signiﬁcant information regarding EtO toxicity. It
also provides possible mechanistic explanation of carcinogenesis.
In this review we discuss EtO toxicity with special emphasis on the
micronucleus assay in human population. The results of micronu-
cleus assay are critically reviewed, highlighting the exposure
concentrations, study design, ﬁndings and the knowledge gaps.
The results are also compared to various other genotoxicity assays,
thus providing an overview regarding the sensitivity of micronu-
cleus assay in EtO bio-monitoring. Finally, the ﬁndings are
summarised, and some recommendations are put forward.
2. Materials and methods
Several epidemiological studies have considered different
aspects of EtO toxicity, including carcinogenicity and mortality.
While many studies have included exposure measurement and EtO
haemoglobin adduct formation (EtO-Hb), only a limited number of
studies have addressed the cytogenetic endpoints. A literature
search was therefore performed till December 2015 using PubMed
and Scopus databases. Search string of “ethylene oxide” [All Fields]
and “Micronucleus” [All Fields] in Pubmed returned a total of 23
results. Search string “Title-Abs-Key (Ethylene Oxide) And Title-
Abs-Key (Micronucleus)” for article published in journals returned
a total of 37 results in Scopus search. These search results included
articles reporting MN formation in animal models and a limited
number of epidemiological evidences. A manual search of these
references was subsequently performed. For the interest of thepresent review, 11 studies were selected based on their inclusion of
micronucleus assay (MN) in human population as one of the test
endpoints. Additionally, some of the evaluated studies also
reported results of sister chromatid exchanges (SCE), chromosomal
aberrations (CA), DNA single-strand breaks (SSB), HPRT mutations.
3. Epidemiological evidence of MN formation in workers
exposed to EtO
The eleven shortlisted studies on workers exposed to ethylene
oxide have been described in this section. The articles were
analyzed with respect to their quality and the observations from
these reports are critically reviewed below and summarised in
Table 1, highlighting the study population, EtO exposure, levels of
EtO-Haemoglobin adducts (EtO-Hb) and the methods and results
of genotoxicity assays performed. For each study reported,
frequency ratio (FR = MN in exposed population/MN in control)
was calculated for micronucleus assay for convenience of
comparison between different studies, and has been represented
in Fig. 1. Additionally, a quality score was assigned to each of the
study out maximum possible score of 27 (Supplementary Table 1).
Högstedt et al. [22] investigated the effect of EtO on different
cytogenetic parameters in an exposed Swedish population. They
studied a group of 28 workers exposed to EtO and 20 control
subjects. The workplace exposure during biological sampling was
less than 1 ppm (8 h-TWA), with occasional high exposure of up to
52 ppm. The workers of two factories and controls were studied for
several cytogenetic parameters including SCE in lymphocyte cells,
and CA and MN in lymphocyte and bone marrow cells. Workers
exposed in both the factories had higher frequency of CA than
controls in lymphocyte cells. The frequency of SCE in lymphocyte
however remained unaltered in the exposed and control groups.
MN in lymphocyte cells revealed no signiﬁcant change (FR for
Factory 1 = 1.16; Factory 2: 0.75). A comparison between the
cytogenetic endpoints indicated that CA was more sensitive in
detecting genotoxic effects of EtO in both lymphocyte and bone
marrow cells. The authors also suggested that bone marrow MN
were good biomarker of EtO toxicity, however its use is limited by
the difﬁculty of sampling.
In a later study, Högstedt et al. [23], compared the cytogenetic
effects of EtO and propylene oxide exposure in a group of Swedish
workers. A total number of 18 subjects (EtO exposed) were
included, with mean age 30.8  8.1. EtO-Hb adducts were
measured and were between 1.2–10 nmol/gHb (mean- 3.3 nmol/
gHb). The authors studied a total of 100 metaphase spreads to
study CA. The percentage of CA in the study population was ﬁve.
MN assay was performed according to the method of Hogstedt
[24]. Brieﬂy, lymphocyte cells were harvested after 72 h of culture,
smear prepared and stained with May-Grunwald-Giemsa’s stain. A
total of 1000 cells were scored. MN frequency in the EtO exposed
workers were reported to be 5.78%. A dose response study among
the workers based on their EtO-Hb levels and MN frequency did
not reveal signiﬁcant correlation. However, since the study lacks a
well-deﬁned control population, it is extremely difﬁcult to
interpret the results of EtO exposure.
To understand the biological effect of EtO, Mayer et al. [25]
evaluated a number of endpoints including EtO-Hb, SCEs, MN, CA,
SSB and index of DNA repair. The study was conducted with 34 (10
male; 24 female) workers exposed to EtO and 24 control subjects.
Workers were exposed to an EtO concentration of 0.1 ppm, while
control population were exposed to much lower levels (below
0.02 ppm). Workplace exposure to EtO signiﬁcantly increased SCE,
and affected DNA repair capacity. The results SCE and DNA repair
assay were strongly correlated with that of EtO-Hb levels. However
CA, SSB were not affected by the workplace exposure to EtO, or
smoking habits. MN formation remained unaltered amongst
Table 1
Summary of epidemiological studies investigating genetic damage in human population exposed to EtO.
Exposure subjects,
country
Year (study
conducted/
published)
Number of participants (age) EtO exposure EtO-Hb Markers of genotoxicity Results and
comments
FR^ QS Ref.
Sterilization of
equipment,
Sweden
1983 E: 28
Factory 1 t: 1m+ 17f (37)
Factory 2 t: 10m (36)
C:
Control IA t: 11f (44)
Control IB t: 8m+2f
Control II t: 9m (29)
t Groups as deﬁned by authors
8h-TWA<1ppm;
momentary peak levels
52ppm
NR MN-lymphocyte
MN in mononuclear cells, 2000
cells scored
MN-bone marrow cells
MN in 1000 PCE and
erythroblast respectively
CA-lymphocyte and bone
marrow)
SCE-lymphocyte
MN-lymphocyte 
$
MN-bone marrow-
"*
CA-"*
SCE- $
Factory 1–1.16
Factory 2: 0.75
14/27 Högstedt
et al. [22]
Sterilizers and
assemblers;
Sweden
1990 E: 18 (30.88.1) 8h-TWA
2ppm
1.2–10 nmol/g Hb
(mean- 3.3 nmol/g
Hb)
MN- MN in mononuclear cells,
1000 cells scored
CA- lymphocyte
MN-lymphocyte 
5.78%
CA-5%
Well deﬁned
control
population
absent
11/27 Högstedt
et al. [23]
Central Sterile Supply
workers; New York,
U.S.A.
1988 E: 10m+24f (36.7010.50)
C: 7m+16f (46.3013.30)
8h-TWA
0.3–0.5 ppm
E: 17017mmol/
mol Hb
C: 6612mmol/
mol Hb
MN- MN in mononuclear cells,
1000 cells scored
CA- lymphocyte
SCE- lymphocyte
MN-lymphocyte 
$
CA-$
SCE- "*
0.95 16/27 Mayer
et al. [25]
Sterilization of
medical equipment
1991 E: 10 (40.4)
C: 10 (39)
6.5 h-TWA
0.025–0.38ppm
E: 78–430pmol/
mg Hb
C: 21–88 pmole/
mg Hb
MN-lymphocyte- MN scored in
1800 binucleated cells
MN-Buccal cells MN in
mononuclear cells, 3000 cells
scored
CA- lymphocyte
SCE- lymphocyte
MN-lymphocyte-
$
MN-Buccal cells-
$
SCE- $
1.18 14/27 Sarto et al.
[26]
Operators of hospital
sterilizers; USA and
Mexico
1992 E: 73; 96% f
(38.328.5; American
participants 13 years older than
Mexican participants)
8h-TWA
USA- 0.04–0.16ppm
Mexico- 0.02–0.54ppm
E: 0.06–
0.16pmol/mg Hb
MN- lymphocytes harvested
at 84 and 96h after initiation,
MN in mononuclear cells, 1000
cells scored
SCE- lymphocyte
MN-lymphocyte 
$
SCE-$ in Mexico
"* USA
Positive association
between EtO-Hb
and SCE
USA- 1.5
Mexico- 1.12
15/27 Schulte
et al. [27]
Sterilization of
medical
equipment;
Germany
1991 tE I: 9 (21–54)
tC I: 8 (24–40)
tE II:15 (29–55)
tC II:15 (30–56)
t Groups as deﬁned by authors
E I: 22–72ppm
8-h TWA of 0.13 ppm
E II: 14–28ppm; peak
around 400ppm
8h-TWA
of 5ppm
E I: 0.179 nmol/g
Hb
C I: 0.066 pmol/g
Hb
E II: 7.70pmol/rng
Hb
C II: 0.102pmol/g
Hb
MN- MN were scored in 1000
binucleated cells
CA- lymphocyte
SCE- lymphocyte
HPRT mutation
MN-lymphocyte 
$ in E I
" in E II
CA-"* in EI and E II
SCE-"* in EI and E II
HPRT mutation-
"* in E II
$ in E I
EI:CI- 1.06
EII:CII- 1.70
18/27 Tates et al.
[28]
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Industry workers;
The Netherlands
1995 Exposed
EIt:7 (3713)
EIIt:7(315)
EIIIt:7(476)
Control
EIVt:7 (448)
EI:incidentally exposed
to acute high doses of 28–
436ppm
EII: exposed to <0.01 for
less than 5 years
EIII: exposed to<0.01 for
more than 15 years
EIV:unexposed
EI: 35–
4902 pmol/g Hb
EII: 0–75pmol/g
Hb
EIII: 0–43pmol/g
Hb
EIV:0–32pmol/g
Hb
Values of March/
May 1993
reported here
MN- MN were scored in 1000/
1500 binucleated cells
CA- lymphocyte
SCE- lymphocyte
HPRT mutation
MN-lymphocyte 
$
SCE- $
HPRTmutation-$
EI:EIV- 0.89
EII:EIV- 1.14
EIII:EIV- 0.93
17/27 Tates et al.
[30]
Industry workers;
Brazil
1994 E: 75m
C: 22m
8h-TWA
2–5ppm
E:294121 nmol/
g Hb
C: 9278 nmol/g
Hb
MN-lymphocyte- MN scored in
1000 binucleated cells
MN-Buccal cells MN in
mononuclear cells, 1000 cells
scored
CA- lymphocyte
SCE- lymphocyte
MN-lymphocyte-
"*
MN-Buccal cells
$
CA-"*
3.63 15/27 Ribeiro
et al. [31]
Hospital workers,
Croatia
1999 E: 11 f
C: 20 f
2ppm NR MN-lymphocyte- MN scored in
1000 binucleated cells
CA- lymphocyte
SCE- lymphocyte
MN-lymphocyte-
"*
CA-"*
SCE-"*
2.93 10/27 Fu9cic et al.
[32]
Hospital workers,
Brazil
2000 E: 10m (35.86.5)
C: 10m (35.97.8)
NR NR MN-lymphocyte- MN scored in
2000 binucleated cells
MN-lymphocyte-
$
CA-"*
0.82 15/27 Maluf and
Erdtmann
[33]
Hospital workers,
South Korea
2011 E: 35 (40.19.7)
C: 62 (40.19.7)
E: 0.010ppm
C: 0.001ppm
# MN-lymphocyte
scored in binucleated cells
MN-lymphocyte-
"*
Not calculated QS not
calculated#
Lee et al.
[35]#
$ Unaltered; " Increase; # Decrease; * signiﬁcant; t: Groups as deﬁned by authors.
#Study published in Korean, hence data presented here are based on limited understanding of the paper, and therefore QS has not been calculated.
m—Male; f—Female; E—Exposed; C—Control; 8 h TWA—8h time weighted average; NR—not reported
QS—Quality score; ^FR—Frequency ration calculated as MN in exposed population/MN in control, calculated only for MN scored in lymphocytes, signiﬁcant values represented in bold
MN—micronucleus; PC—polychromatic erythrocyte; CA—Chromosomal aberration; SCE—Sister Chromatid Exchange; EtO-Hb- EtO-Haemoglobin adducts; Hb—Haemoglobin
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Fig. 1. Comparison of frequency ratio of MN in workers exposed to EtO, the values adjacent to the bars represent the average exposure concentrations, details of which can be
found in Table 1.
88 M. Ghosh, L. Godderis / Mutation Research 770 (2016) 84–91workers and control (FR = 0.95). The study results suggest a poor
correlation between MN formation and EtO exposure in general
and EtO-Hb adduct formation in particular. The authors suggested
that SCEs might be more sensitive to EtO exposure than MN and
CA.
Sarto et al. [26], studied 10 sterilization workers, to understand
the effect of EtO exposure on adduct formation and different
cytogenetic parameters. The study included a control group of 10
unexposed nurses from the same hospital. The mean exposure to
EtO was 0.025–0.38 ppm. Among the 10 workers, 3 were subjected
to an accidental exposure to EtO, but for a very short duration. EtO-
Hb concentrations were measured to describe the exposure. The
exposed group (78–430 pmol/ mg Hb) had a signiﬁcantly higher
amount of adducts, compared to the control (21–88 pmol/ mg Hb).
SCE and MN were performed to understand the cytogenetic effect
of EtO exposure. The mean SCE frequency in the exposed workers
was not statistically different from the control. MN formation were
studied in lymphocyte cells, however no signiﬁcant difference was
observed between exposure and control groups (FR = 1.18). Similar
observations were made for MN formation in buccal cells.
Sarto et al. [9] reported in another publication the effect of EtO
exposure on exfoliated cells of the nose and mouth. MN was
studied in a group of 9 subjects working in sterilization unit,
exposed to 8 h-TWA concentration < 0.38 ppm. Additionally, the
study reported also data of an accidental exposure to higher levels
of EtO in 3 of the workers. The frequency of MN in buccal mucosa
remained unaltered as previously reported by the group. In
contrast, the MN frequency in nasal mucosa was altered in 2 of the
subjects, accidentally exposed to higher concentrations of EtO. The
chronic exposure did not alter the MN frequency.
In a later study by Schulte et al. [27], similar association
between SCE, MN and EtO-Hb were observed. Schulte et al. [27]
studied a total of 73 workers, mostly female (96%) from nine
hospitals in the USA and one hospital in Mexico City. EtO exposure
was monitored over a period of 4 months before the sampling. The
8 h TWA exposure to EtO was determined to be between 0.02 ppmand 0.54 ppm. Based on the EtO exposure the subjects were
grouped as not exposed (0 ppm 8 h-TWA), low exposure (0.02-
0.30 ppm 8 h-TWA) and high exposure (0.13–1.36 ppm 8 h-TWA). A
strong association between EtO exposure, EtO-Hb adduct and SCE
formation were observed by the authors. The MN formation was
studied using the method of Hogstedt et al. [24] in lymphocytes
and a minimum of 1000 cells were scored for the analysis. No
signiﬁcant changes in MN frequency (expressed as frequency/cell)
were observed in the American population, between the non-
exposed (0.51 ppm), low exposure (0.48 ppm) and high exposure
groups (1.06 ppm) (FR = 1.51). Similar results were observed for the
Mexican population as well (FR = 1.12).
A study by Tates et al. [28] investigated the effect of EtO in
German workers involved in Sterilization of medical equipment.
The group of workers (EI: 22–72 ppm and EII: 14 and 28 ppm;
occasional peak exposure 400–700 ppm) was matched for age, sex
and smoking habits with the control groups (Control: CI and CII).
The values of EtO-Hb adduct were signiﬁcantly higher in the
exposed group (E I: 0.179 nmol/g Hb; E II: 7.70 pmol/rng Hb) when
compared to their respective controls (C I: 0.066 pmol/ g Hb; C II:
0.102 pmol/ g Hb). In addition to exposure measurement, all
samples were analyzed for HPRT mutants (MFs), SCEs, CA and
MN. While SCE and CA were signiﬁcantly higher, MF for exposed
group was unaltered. Unlike in the previous studies, in the present
study MN were studied in binucleated cells according to the
method of Fenech and Morley [29]. The results suggested no
signiﬁcant change in MN frequency between E I and C I (FR = 1.06).
However, the number of MN in higher exposure group E II was
signiﬁcantly higher compared to C II (FR = 1.70). The relative
sensitivity of endpoints studied was suggested to be in the
following order: EtO-Hb adducts > SCEs > CA > MN > HPRT mutants.
A later study by Tates et al.[30] considered four exposure groups
to understand the effect of incidental and chronic low dose
exposure. The groups were well deﬁned based on the number of
subjects, concentration and duration of exposure, smoking habits
(Table 1, EI-E IV). EtO-Hb adduct reﬂected the concentration and
M. Ghosh, L. Godderis / Mutation Research 770 (2016) 84–91 89duration of exposure in each of the four groups. No signiﬁcant
change in HPRT mutation and SCE were observed. Whole blood
culture was established to study the formation of MN in 1000–
1500 binucleated lymphocyte cells. The number of MN/1000 cells
in all the groups were between 15 and 16 (FR = EI: EIV-0.89;
EII: EIV-1.14; EIII: EIV-0.93). The authors provided for a possible
explanation, that since the sampling was 3 months after the
incidental exposure, the damages could have been repaired
and hence were not detected in the assays. They also inferred
that the mutagenic/cytogenetic changes induced by EtO were not
permanent.
In another important study Ribeiro et al. [31] investigated the
effect of EtO in exposed works (n = 75) from Brazil. The study
included 22 control subjects. EtO concentrations in ambient air
were measured over a period of 3 months. The workers were
exposed to an 8 h-TWA concentration of 2–5 ppm EtO. EtO-Hb
adduct in the exposed group (294 121 nmol/g Hb) were
signiﬁcantly higher compared to the control population (92  78
nmol/g Hb). However the results are limited by fact that it was
measure only in 8 workers and 5 controls. Results of CA indicated a
signiﬁcant increase in aberration in the exposed group compared
to the control. Cytokinesis-blocked MN (CBMN) assay was
performed in lymphocytes. However, MN was performed only in
16 workers and 11 control samples. Thousand binucleated cells
were scored for the assay. A signiﬁcant increase in the number of
MN were observed in exposed workers (FR = 3.6). Additionally MN
was studied in exfoliated epithelial cells; however exposure to EtO
did not affect the MN frequency (FR = 1.18). Rapid renewal and
alternative route of EtO exposure were put forward as explanation
for the absence of MN in exfoliated cells.
Fu9cic et al. [32], conducted a pilot study with 11 exposed and 20
control female subjects working in a Croatian hospital. The average
exposure during sterilization process was reported to be 2 ppm.
Cytogenetic endpoints like SCE, CA and MN were studied in
lymphocyte cells. A signiﬁcant increase in SCE frequency was
observed in the exposed population. Higher numbers of chromo-
some breaks were observed in the exposed group (5.5) as
compared to the control (0.7). MN assay was performed in
lymphocyte cells according to the method of Fenech and Morley
[29]. A signiﬁcant increase in MN formation was observed in the
exposed workers.
A study by Maluf and Erdtmann [33] investigated 10 subjects
(male, 35.8  6.5) from a Brazilian hospital, occupationally exposed
to EtO. The control group comprised of ten age and sex matched
(male, 35.9 7.8) population. The authors performed MN assay
according to the methods of Fenech [34]. The presence of MN were
determined in 2000 binucleated cells per individual, however no
signiﬁcant alterations were observed (FR = 0.82).
Lee et al. [35] investigated the role of GSTM1, GSTT1, XRCC1, and
XRCC3 polymorphism and genotoxicity in an epidemiological
setup. However, this article published in the Korean Journal of
Environmental Health Sciences [35] is in Korean, which limits our
understanding of the manuscript. The results could only be
discussed to a limited extent based on the abstracts, tables and
ﬁgures. The study population comprised of 35 occupationally
exposed workers, and 62 controls. The average age of the control
group was 31.6  12.5 years, while that of the exposed group was
40.1 9.7 years. The frequencies of micronuclei (CBMN assay) in
EtO exposure group were signiﬁcant higher, compared to the
control group. A dose-response between MN frequency EtO
exposure was observed but was not statistically signiﬁcant. The
authors investigated the role of GSTM1, GSTT1, XRCC1, and XRCC3
polymorphism on MN frequency but no association was observed.
The ﬁndings by Lee et al. [35] were consistent with that reported by
Godderis et al. [36]. However, the EtO concentration for exposed
population (0.010 ppm) and control (0.001 ppm), were notsigniﬁcantly different as in most other studies which could
possibly explain the lack of difference between the group.
4. Discussion
Based on animal studies and epidemiological evidences, EtO
has been categorized as “carcinogenic to humans (Group 1)” by
IARC. However, the ﬁndings from human studies are often
inconsistent and inconclusive as highlighted by the IARC Mono-
graph [4–6]. A limited number of study have reported the mortality
and cancer incidence in workers exposed to EtO [17–19,37–40],
while some have reported otherwise [40–43]. In addition to
carcinogenicity studies, signiﬁcant information regarding toxicity
of EtO in human population has been obtained from results of
haemoglobin adduct formation, chromosomal aberrations (CA),
sister chromatid exchange (SCE), micronucleus assay (MN) among
others. For the interest of the present review, we discuss the results
obtained from micronucleus assay in human lymphocyte cells,
highlighting the lacunae. The review has been based on a limited
number of (n = 11) papers, shortlisted by authors based on their
inclusion of MN assay. Interestingly most of the studies discussed
were published between 1985 and 2000, before EtO was classiﬁed
as “known to be a human carcinogen” in the Ninth Report on
Carcinogens in 2000 [21].
It would be important to understand that from the limited
number of studies discussed in the review, it is difﬁcult to make a
general conclusion regarding micronucleus assay. While MN has
been studied in lymphocyte cells, quantitative evaluations of the
data with respect to exposure could not be performed due to
uncertainties in the concentration and duration of exposure, time
points selected and small size of the population. In addition, some
of these studies lack proper description of the method used and
subsequent scoring of micronucleus. In this section the different
points affecting the sensitivity and assay outcome have been
discussed in brief.
While all of the discussed studies scored MN in lymphocyte
cells, the cell type chosen to initiate cell culture varied
signiﬁcantly. While many of these studies have used whole blood
to initiate culture [28,30], others have used isolated lymphocyte for
the assay. The time used for cell culture also varied considerably
from one study to the other. Mayer et al. [25], harvested cells after
64–66 h of culture to study MN, while Schulte et al.[27], harvested
cells at 84 and 96 h. Tates et al. [28,30], in their study used a total
culture time of 72 h, with Cytochalasin B added after the 44 h.
However the most important aspect that makes these studies
incomparable is the form of MN assay used. In some of the studies
MN were evaluated in mononuclear cells [23,25,27], while in
others the CBMN assay was used.
For a better understanding of the results discussed, with respect
to EtO 8 h-TWA exposure, the results of the different MN assays (in
mononucleate and binucleated cells) were compared indepen-
dently. The mean MN frequencies (FR = 0.75-3.63) obtained from
these studies were compared to the EtO exposure concentrations.
A poor correlation between MN formation and EtO exposure
concentrations (CBMN, R = 0.154; MN in mononucleate cells,
R = 0.132) were observed from these studies. It might be important
to mention here, that positive results of MN were observed in only
three of the studies reported [28,31,32], where the EtO exposure
concentrations were much higher (2–28 ppm 8 h-TWA) than the
present recommended levels (<1 ppm). At the concentration lower
than 1 ppm, MN formation was not observed [23,25–31,30,33]
irrespective of the form of MN assay used.
Additionally, it can be pointed out that sample size plays an
important role in the sensitivity of MN assays in the discussed
studies. By calculating the mean difference (=0.62) between
control and exposed population (R = 0.148), a required sample size
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was obtained. This value is much higher than that reported in any
of these studies (n = 7-75). A power calculation based on the above
studies might be reﬂective of the sensitivity of MN assays.
However, a calculation would be more appropriate based on age
and gender matched pilot study, which would allow establishing
background values of MN formation in the population at a more
realistic exposure scenario.
These studies additionally provided some insight regarding the
choice of cells and their inﬂuence on the micronucleus assay.
Högstedt et al. [22] in their study indicated that MN assay in bone
marrow cells was a better indicator than lymphocyte MN. In some
of the other studies MN formation was evaluated in exfoliated
buccal and nasal cells, in addition to lymphocyte cells. In the study
by Sarto et al. [26] the MN frequency in both buccal and
lymphocyte cells remained unaltered by the EtO exposure. Sarto
et al. [9], in another publication, reported higher MN frequency in
nasal mucosa in 2 subjects accidentally exposed to higher
concentrations of EtO. While Ribeiro et al. [31], reported a 3.5
fold increase in the number of MN in lymphocyte cells, however no
such effect were observed in the exfoliated cells. Given the
difference in sensitivity of different cell types observed from the
limited number of studies, it would be interesting to compare the
effect of EtO exposure on MN formation in exfoliated buccal and
nasal cells (source of exposure), lymphocyte (circulatory system),
and urothelial cells (excretion of metabolites).
The results of the studies additionally reveal that MN is
relatively less sensitive towards EtO exposure, when compared to
other cytogenetic endpoints like SCE and CA. In the studies [25–28]
where SCE, CA and MN were performed simultaneously, SCE was
found to be most sensitive, followed by CA and MN respectively.
The levels of EtO and EtO-Hb adducts in all the studies were
strongly correlated to the results of SCE and not MN.
5. Conclusion and recommendation
From the studies discussed in the present review, interpretation
of results based on the MN assay has been limited by the lack of a
harmonized protocol, use of proper cell culture/harvesting
conditions and scoring criteria. Moreover the positive results have
often been reported at a much higher concentrations (2–30 ppm),
and in a very small number of subjects (often n = < 10). From the
limited number of studies available, it is extremely difﬁcult to
determine sensitivity or understand dose response of MN assay
towards EtO exposure. To clearly understand the effect of exposure
of EtO on MN assay outcome, the following lacunae should be
addressed:
i. Use of a harmonized protocol for exposure assessment and MN
assay (CBMN cytome assay)
ii. Studies should be designed based on power calculation to
determine suitable samples size
iii. Use of multiple target tissues, to determine sensitivity of MN
for EtO bio-monitoring studies.
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